Literature DB >> 18382742

Kinetoplastids: related protozoan pathogens, different diseases.

Ken Stuart1, Reto Brun, Simon Croft, Alan Fairlamb, Ricardo E Gürtler, Jim McKerrow, Steve Reed, Rick Tarleton.   

Abstract

Kinetoplastids are a group of flagellated protozoans that include the species Trypanosoma and Leishmania, which are human pathogens with devastating health and economic effects. The sequencing of the genomes of some of these species has highlighted their genetic relatedness and underlined differences in the diseases that they cause. As we discuss in this Review, steady progress using a combination of molecular, genetic, immunologic, and clinical approaches has substantially increased understanding of these pathogens and important aspects of the diseases that they cause. Consequently, the paths for developing additional measures to control these "neglected diseases" are becoming increasingly clear, and we believe that the opportunities for developing the drugs, diagnostics, vaccines, and other tools necessary to expand the armamentarium to combat these diseases have never been better.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18382742      PMCID: PMC2276762          DOI: 10.1172/JCI33945

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  125 in total

1.  Comparative genomics of trypanosomatid parasitic protozoa.

Authors:  Najib M El-Sayed; Peter J Myler; Gaëlle Blandin; Matthew Berriman; Jonathan Crabtree; Gautam Aggarwal; Elisabet Caler; Hubert Renauld; Elizabeth A Worthey; Christiane Hertz-Fowler; Elodie Ghedin; Christopher Peacock; Daniella C Bartholomeu; Brian J Haas; Anh-Nhi Tran; Jennifer R Wortman; U Cecilia M Alsmark; Samuel Angiuoli; Atashi Anupama; Jonathan Badger; Frederic Bringaud; Eithon Cadag; Jane M Carlton; Gustavo C Cerqueira; Todd Creasy; Arthur L Delcher; Appolinaire Djikeng; T Martin Embley; Christopher Hauser; Alasdair C Ivens; Sarah K Kummerfeld; Jose B Pereira-Leal; Daniel Nilsson; Jeremy Peterson; Steven L Salzberg; Joshua Shallom; Joana C Silva; Jaideep Sundaram; Scott Westenberger; Owen White; Sara E Melville; John E Donelson; Björn Andersson; Kenneth D Stuart; Neil Hall
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

2.  Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene.

Authors:  S C Welburn; K Picozzi; E M Fèvre; P G Coleman; M Odiit; M Carrington; I Maudlin
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

Review 3.  Post-kala-azar dermal leishmaniasis.

Authors:  V Ramesh; A Mukherjee
Journal:  Int J Dermatol       Date:  1995-02       Impact factor: 2.736

4.  Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness.

Authors:  C Schmid; S Nkunku; A Merolle; P Vounatsou; C Burri
Journal:  Lancet       Date:  2004 Aug 28-Sep 3       Impact factor: 79.321

Review 5.  The regulation of immunity to Leishmania major.

Authors:  S L Reiner; R M Locksley
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

6.  Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up.

Authors:  R Viotti; C Vigliano; H Armenti; E Segura
Journal:  Am Heart J       Date:  1994-01       Impact factor: 4.749

7.  The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense.

Authors:  Magdalena Radwanska; Mustapha Chamekh; Luc Vanhamme; Filip Claes; Stefan Magez; Eddy Magnus; Patrick de Baetselier; Philippe Büscher; Etienne Pays
Journal:  Am J Trop Med Hyg       Date:  2002-12       Impact factor: 2.345

Review 8.  Immune system recognition of Trypanosoma cruzi.

Authors:  Rick L Tarleton
Journal:  Curr Opin Immunol       Date:  2007-07-24       Impact factor: 7.486

Review 9.  Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.

Authors:  O Heby; L Persson; M Rentala
Journal:  Amino Acids       Date:  2007-07-04       Impact factor: 3.520

10.  Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis.

Authors:  Hashim Ghalib; Farrokh Modabber
Journal:  Kinetoplastid Biol Dis       Date:  2007-08-17
View more
  231 in total

1.  CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.

Authors:  Charles S Rosenberg; Dianya L Martin; Rick L Tarleton
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Comparative diagnosis of parasitological, serological, and molecular tests in dourine-suspected horses.

Authors:  Fikru Regassa Gari; Hagos Ashenafi; Alemu Tola; Bruno M Goddeeris; Filip Claes
Journal:  Trop Anim Health Prod       Date:  2010-06-06       Impact factor: 1.559

3.  Prophylactic antiparasitic transgenesis for human parasitic disease?

Authors:  Julius Lukeš; Jayne Raper
Journal:  Mol Ther       Date:  2010-10       Impact factor: 11.454

4.  Symmetrical choline-derived dications display strong anti-kinetoplastid activity.

Authors:  Hasan M S Ibrahim; Mohammed I Al-Salabi; Nasser El Sabbagh; Neils B Quashie; Abdulsalam A M Alkhaldi; Roger Escale; Terry K Smith; Henri J Vial; Harry P de Koning
Journal:  J Antimicrob Chemother       Date:  2010-11-14       Impact factor: 5.790

5.  Scanning and three-dimensional electron microscopy methods for the study of Trypanosoma brucei and Leishmania mexicana flagella.

Authors:  Eva Gluenz; Richard John Wheeler; Louise Hughes; Sue Vaughan
Journal:  Methods Cell Biol       Date:  2015-03-07       Impact factor: 1.441

6.  Emerging roles of PPR proteins in trypanosomes: switches, blocks, and triggers.

Authors:  Ruslan Aphasizhev; Inna Aphasizheva
Journal:  RNA Biol       Date:  2013-08-29       Impact factor: 4.652

7.  UDP-galactopyranose mutases from Leishmania species that cause visceral and cutaneous leishmaniasis.

Authors:  Isabel O Fonseca; Karina Kizjakina; Pablo Sobrado
Journal:  Arch Biochem Biophys       Date:  2013-09-03       Impact factor: 4.013

8.  Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.

Authors:  Charles S Rosenberg; Weibo Zhang; Juan M Bustamante; Rick L Tarleton
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

Review 9.  Motility and more: the flagellum of Trypanosoma brucei.

Authors:  Gerasimos Langousis; Kent L Hill
Journal:  Nat Rev Microbiol       Date:  2014-07       Impact factor: 60.633

10.  Synthesis, DNA binding and antileishmanial activity of low molecular weight bis-arylimidamides.

Authors:  Moloy Banerjee; Abdelbasset A Farahat; Arvind Kumar; Tanja Wenzler; Reto Brun; Manoj M Munde; W David Wilson; Xiaohua Zhu; Karl A Werbovetz; David W Boykin
Journal:  Eur J Med Chem       Date:  2012-07-14       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.